Italy

 

European nursing homes – a five market comparison

This week we take a closer look at how the elderly residential nursing home market stacks up, specifically in five major European markets - France, Spain, Germany, Italy and UK. Here we compare the total, and for profit and public/not-for-profit market revenues, and look at where the international operators have the largest revenues. These figures are a snapshot of the position based on revenues in 2020 taken from our nursing homes reports in HBI Intelligence and the operator database.
May 13, 2022

Affidea deal – underbidders and EBITDA

HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.
April 28, 2022

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
April 19, 2022

For-profit dentistry consolidation in Europe

This week, we look at the extent to which the for-profit dentistry market is consolidated in five major European countries – France, Germany, UK, Spain and Italy. These figures are a snapshot of the position based on revenues in 2020 taken from HBI Intelligence - and show why interest in dentistry is so high.
April 14, 2022

KKR set to acquire IVI-RMA

Multiple sources say US-based buyout specialist KKR is close to closing a deal to buy Spain-based global fertility player IVI-RMA, the largest group in the sector by revenue.
March 31, 2022

Doctolib France’s biggest Unicorn

Now the largest unicorn in France, Doctolib is valued at €5.8b, three years after it reached unicorn status, despite still making a loss. HBI speaks to a French healthcare consultant and expert to find out how.
March 24, 2022

Icade Sante considering H2 for IPO attempt part deux

At the end of last year, healthcare specialist REIT Icade Santé looked to fall victim to capital markets' apathy for European healthcare services, postponing its IPO. Could it be looking to try again in H2 2022 - or is it too soon to try?
March 23, 2022

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?
March 17, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us